Eileen C. King, PhD, has extensive experience (26 years) as a statistical leader in the design, analysis, andinterpretation of results from animal and human clinical research studies. As Head of the Department ofBiometrics and Statistical Sciences at Procter & Gamble Pharmaceuticals, Dr. King provided statisticalguidance and support concerning the design and analysis of clinical studies and the effectivepresentation and interpretation of the results to many projects. She has been responsible for the design,management and analysis of studies in all stages of pharmaceutical drug development, including drugdiscovery, early and late stage drug development, commercialization, and market support. Dr. Kingjoined Cincinnati Children’s Hospital Medical Center in 2009 and continues to provide statistical andclinical data management guidance and support to several research areas at CCHMC. Dr. King is anactive member of the American Statistical Association and currently serves on the Board of Directors.